Related Experiment Videos
125I-vasoactive intestinal peptide binding in human kidney
B G Charlton1, D E Neal, N L Simmons
1Department of Anatomy, University of Glasgow, UK.
Mineral and Electrolyte Metabolism
|January 1, 1991
Summary
Researchers investigated vasoactive intestinal peptide (VIP) receptors in human kidneys. Specific VIP binding sites were found in the renal cortex, suggesting VIP plays a role in regulating urine electrolytes.
Area of Science:
- Nephrology
- Endocrinology
- Molecular Biology
Background:
- Vasoactive intestinal peptide (VIP) is implicated in regulating various physiological functions.
- Its specific role and receptor interactions within the human kidney remain incompletely understood.
Purpose of the Study:
- To investigate the presence and characteristics of specific intrarenal VIP receptors in human kidney tissue.
- To determine if VIP binding is localized to specific regions of the kidney.
Main Methods:
- Isolated plasma membranes from human kidney tissue (nephrectomy specimens).
- Quantified 125I-VIP binding using equilibrium binding assays and rapid filtration.
- Utilized autoradiography to map the distribution of specific VIP binding sites.
Main Results:
- Specific, saturable binding of 125I-VIP was observed in human kidney plasma membranes.
- Evidence of both high- and low-affinity VIP binding sites was detected.
- Autoradiography revealed that specific VIP binding is localized to the renal cortex.
- Binding was partially inhibited by homologous peptides and a VIP antagonist.
Conclusions:
- The human kidney possesses specific VIP binding sites, primarily located in the renal cortex.
- These findings support the hypothesis that VIP exerts its renal effects through dedicated intrarenal receptors.
- VIP likely plays a role in regulating human urine electrolyte composition.